Biotechnology companies require substantial financing for product development, research, and expansion. Consequently, project financing emerges as a strategic solution, eliminating the need for company resources. With adequate financial support, these companies can, therefore, concentrate on innovation, regulatory approvals, and market expansion. As a result, large-scale biotech projects necessitate long-term financial planning. Funding is structured based on project viability, thereby ensuring extended repayment periods that align with revenue generation.
Facilitate funding, including equity and debt
Good Rate of Interest
A Project serves as the collateral itself
It involves multiple participants
Repayment relies on the project's future cash flow
(*T&C Applied)
Project financing provides biotech companies with funding, ensuring long-term sustainability. It allows businesses to fund large-scale projects without depleting working capital.
To qualify for project financing, a biotech company must demonstrate its project’s viability and financial sustainability.
Having the right documents speeds up the financing process. Here are the essential documents required for project financing:
At Terkar Capital, we specialize in customized financing solutions for biotechnology firms. Our project financing options ensure structured financial support for R&D, product development, and expansion. Whether launching a new facility or scaling up production, our expertise helps secure funding with the best terms.
We offer competitive loan terms aligned with your project’s cash flow and end-to-end guidance from application to disbursement. Additionally, our loan processing is quick and efficient, with flexible funding solutions designed to meet the needs of biotech companies at all stages of growth. Finally, we offer expert advisory services to help maximize financial benefits.
Unlike standard business loans, project financing is structured around the success of a specific biotech project, with repayments tied to project revenue.
Projects related to R&D, clinical trials, manufacturing facility expansion, and technology development can qualify for financing.
Collateral requirements vary. Some financing options are asset-backed, while others rely on projected revenue streams.
Approval timelines vary but typically range from a few weeks to a few months, depending on project complexity.
Yes, depending on regulatory and financial feasibility, cross-border biotech projects can secure financing.
Delhi | Bengaluru | Chennai | Kolkata | Ahmedabad | Surat
Growing Nationwide…
Note: All formal communication is solely via designated official emails.
